Menu
Search
|

Menu

Close
X

NxStage Medical Inc NXTM.OQ (NASDAQ Stock Exchange Global Select Market)

27.64 USD
+0.25 (+0.91%)
As of Jul 21
chart
Previous Close 27.39
Open 27.38
Volume 99,124
3m Avg Volume 134,243
Today’s High 27.92
Today’s Low 27.38
52 Week High 29.93
52 Week Low 22.70
Shares Outstanding (mil) 66.01
Market Capitalization (mil) 1,827.08
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 6 analysts

KEY STATS

Revenue (mm, USD)
FY18
107
FY17
394
FY16
366
FY15
336
EPS (USD)
FY18
-0.022
FY17
0.581
FY16
-0.074
FY15
-0.243
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
4.83
5.73
Price to Book (MRQ)
vs sector
8.44
5.47
Price to Cash Flow (TTM)
vs sector
69.22
23.29
Total Debt to Equity (MRQ)
vs sector
6.51
16.84
LT Debt to Equity (MRQ)
vs sector
5.50
12.51
Return on Investment (TTM)
vs sector
-2.71
14.61
Return on Equity (TTM)
vs sector
-2.44
16.34

EXECUTIVE LEADERSHIP

Robert Funari
Independent Chairman of the Board, Since 2014
Salary: --
Bonus: --
Joseph Turk
President, Since 2013
Salary: $408,500.00
Bonus: $150,764.00
Jeffrey Burbank
Chief Executive Officer, Director, Since 2011
Salary: $638,281.00
Bonus: $376,910.00
Matthew Towse
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer, Since 2015
Salary: $365,298.00
Bonus: $111,199.00
Winifred Swan
Senior Vice President, General Counsel, Since 2005
Salary: $352,331.00
Bonus: $86,689.00

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

350 Merrimack St
LAWRENCE   MA   01843-1748

Phone: +1978.6874700

NxStage Medical, Inc. is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate preparation equipment and the sale of disposable products in the home and critical care markets. The In-Center segment includes revenues from the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease patients at dialysis clinics, and needles for apheresis. It markets extracorporeal disposable products under the Medisystems brand. The Services segment includes revenues from dialysis services provided to patients at its NxStage Kidney Care dialysis centers. Its product offerings include Home Dialysis, Next-Generation Hemodialysis System, Critical Care, Next-Generation Critical Care System and In-Center.

SPONSORED STORIES